Gerald S. Bloomfield, MD, MPH DGHI, Division of Cardiology, Duke University September 2013 Non-Communicable Diseases in LMICs: Myths, Facts and Opportunities.

Slides:



Advertisements
Similar presentations
noncommunicable diseases
Advertisements

Health Statistics and Informatics Global Health Risks: Selected figures and tables Health Statistics and Informatics Department.
Nutrition in Health and Disease: Implications for Public Health in Russian Federation First Forum on NCD (Non-communicable Disease) Prevention and Healthy.
Bridget Dillon February 11,  Cardiovascular disease affects the heart and circulatory system. It is often a result of blockages of blood vessels.
Burden of Cardiovascular Disease in Mississippi. Top Ten Leading Causes of Death in Mississippi, 2007 Source: Mississippi Vital Statistics, 2007.
Global Burden of Chronic Disease : Focus on CVD
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 4.
Zhai, Public Health Nutrition, Feb 2002 WHAT IS CHINA DOING IN POLICY-MAKING TO PUSH BACK THE NEGATIVE ASPECTS OF THE NUTRITION TRANSITION? Fengying Zhai.
H.I. GHOSH1 Challenges of NCDs in Palestine *** Heidar Abu Ghosh Director of Chronic Diseases Program *** Palestinian Medical Relief Society.
Chapter Twelve Importance of Noncommunicable Disease.
E NHANCING C OMPREHENSIVE HIV C ARE : Addressing Cardiovascular Disease (CVD) and other Noncommunicable Diseases (NCDs) Kwasi Torpey MD PhD MPH FGCP Deputy.
Coronary Heart Disease (CHD): A Disease of Affluence.
Epidemic of Cardiovascular disease Global and US trends Any Lessons for Honduras? Dr. Thomas G. Allison Cardiovascular Diseases and Internal Medicine Mayo.
Chronic Disease in Missouri: Progress and Challenges Shumei Yun, MD, PhD Public Health Epidemiologist and Team Leader Chronic Disease and Nutritional Epidemiology.
World Health Organization TOWARDS A GLOBAL DIET AND PHYSICAL ACTIVITY STRATEGY APPROACH - PROGRESS - CHALLENGES DEREK YACH EXECUTIVE DIRECTOR NONCOMMUNICABLE.
INTERNATIONAL & GLOBAL HEALTH CONCEPTS & CURRENT ISSUES 1 Dr. Mohammad Afzal Mahmood, Prof Ahmed Mandil, Dr. Salwa Tayel Department of Family & Community.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Chronic Disease – Management Priorities in the 21st Century V.K. Barbiero, PhD, MHS George Washington University Department of Global Health.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Child deaths: Causes and epidemiological dimensions Robert E. Black, M.D., M.P.H. Johns Hopkins Bloomberg School of Public Health.
Non-communicable diseases David Redfern
Climate change and noncommunicable diseases: the nutrition connection © Samuel Hauenstein Swan PHI satellite event at the High Level Meeting on Non-Communicable.
Do you know someone who has been a victim of a heart attack or stroke? VideoVideo - Watch your own heart attack.
Combating disease and improving health Presented by ROSANNA AGBLE at Taking Action for the World’s Poor and Hungry People Beijing, China October 17–19,
T.D. Medical College,Alappuzha
Definition of the ‘health transition’
HYPERTENSION BURDEN AND CVD RISK PREDICTION IN AFRICA.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
Terms: Epidemiologic Transition Gaziano 2005 Stage 1Malnutrition and infectious diseases are the leading causes of mortality and morbidity Stage 2Improved.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
Non-Communicable Diseases Control Program _________________________________ K R Thankappan MD, MPH Additional Professor and Head Achutha Menon Centre.
Estimating alcohol’s role in disease & disability: the alcohol component in WHO’s Global Burden of Disease analysis for 2000 David Jernigan Center on Alcohol.
4 th SIDS Meeting, Sao Tome & Principe April |1 | NCDs in the context of the revised Health Promotion Strategy.
NON COMMUNICABLE DISEASES( NCDs) By NSABIMANA Olivier Philemon, B.Pharm. ASEPA / UNR From 19/4-3/5 /2014.
Dr. Joseph Mbatia Assistant Director and Head, NCD, Mental Health and Substance Abuse Ministry of Health and Social Welfare (Tz. Mainland)
EPIDEMIOLOGY OF CHRONIC NON COMMUNICABLE DISEASES (NCDs)
The Impact of Heart Disease and Stroke in Michigan: 2008 Report on Surveillance November 3, 2008.
1 Cardiovascular Disease in Asia. WHO CVD Atlas WHO Stroke Atlas The Burden of CVD in Asia: Stroke Deaths by Country,
Health transition and emerging cardiovascular disease in developing countries: situation and strategies for prevention Pascal Bovet,
Global Patterns of Disease IB Geography II. Objective By the end of this lesson, students will be able to: –explain the global distribution of diseases.
Definition of the ‘health transition’
Health Statistics and Informatics Non-communicable diseases A global overview.
2007 Hypertension as a Public Health Risk January, 2007.
Meeting the Challenge of Non-Communicable Diseases Lecture 14.
The Disease Control Priorities Project ( and Chronic Disease Presentation to the Hemispheric Meeting of the Social Protection.
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
Global Health in the News price-hike-AIDS-drug-claiming-HELPING-need-life-saving-medication-funds-research-
Linkages between CDs & NCDs: The African context Dr Frank J Mwangemi ICASA 2011: 5 th December 2011 Addis Ababa, Ethiopia.
Heavy Burden: Heavy Burden: Multiple Risk Factor Profile In Hypertension Patients Dong Zhao MD, PhD Department of Epidemiology Beijing Institute of Heart,
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
Cardiovascular Risk: A global perspective
HIV and NCD overview 21 st International AIDS Conference Durban 2106 Dr Tolu Oni Senior Lecturer & Public Health Medical Specialist University of Cape.
FIGURE 1-2 CARDIOVASCULAR DISEASE DEATHS AS A PERCENTAGE OF ALL DEATHS IN EACH REGION AND TOTAL REGIONAL POPULATION, (DATA FROM MATHERS CD, LOPEZ.
World Health Organization
Chronic respiratory diseases: burden, population and interventions,
NCDs: global situation and response
Noncommunicable Diseases: An Overview
Epidemiology, Burden and Primary Prevention of Cardiovascular Disease Dr Shanthi Mendis MBBS MD FRCP FACC Coordinator Chronic Disease Prevention.
Noncommunicable Diseases: An Overview
How does teamwork improve value. Dr Nils E
Preventing Cardiovascular Disease
Demography and Alzheimer’s Disease: The 21st Century Fiscal Nightmare
NCDs and Alzheimer’s 26th International Conference of Alzheimer's Disease International: The Changing Face of Dementia Toronto, Ontario Canada March 27,
Hypertension Update: How Low Shall We Go?
Recognizing Your Risk for Cardiovascular Disease
Cardiovascular Disease (CVD) in Texas
عوامل تهديد كننده ي سلامت
NCDs: global situation and response
Presentation transcript:

Gerald S. Bloomfield, MD, MPH DGHI, Division of Cardiology, Duke University September 2013 Non-Communicable Diseases in LMICs: Myths, Facts and Opportunities

 Trends in selected NCDs in LMICs  Epidemiologic transition  Data challenges  Approaches to NCD research in LMICs OUTLINE

CARDIOVASCULAR DISEASE

 Common CVDs: Rheumatic, infectious, pericardial, high BP  Heart failure is endemic in SSA  Dilated cardiomyopathy: 48% of admissions  Causes: RHD, Hypertension, Peripartum, Idiopathic  Coronary heart disease “distinctly rare”  Diagnostic limitations  Lack of specialized investigations  Viral, nutritional, familial, alcohol, immune, ischemia  68% of ‘idiopathic’ can be mislabeled CLASSIC TEACHING ON CARDIOVASCULAR DISEASES IN SSA RHD = Rheumatic Heart Disease Watkins and Mayosi. Cardiovascular Journal of Africa 2009 BP = blood pressure Oyoo and Ogola. East African medical journal 1999 Mokhobo. S Afr Med J 1980

“Africans are immune to heart/coronary disease” Ancient Egypt 1370 BC Heavy Heart is a Bad Heart Kenya.2 years, 1800 patients. 0% HTN, arteriosclerosis Uganda.2 years 0% HTN Kalahari San. No increase in BP with age No change in BP with age Prev. HTN Ghana 13% Nigeria 25% Lesotho 7% History of chronic CVD in Africa 1920s s Uganda. N= 1500 “High tension pulses not often met with” : 8-11% admissions due to CVD s 40% hospital admissions with any CVD 2010:CVD is the 2 nd most common cause of death in SSA

 325 migrants, 267 controls followed for 24 months  SBP changes over 24 months LUO MIGRATION STUDY Poulter BMJ 1990

PULMONARY DISEASE

DEATHS DUE TO PULMONARY DISEASE

Adult Smoking Prevalence, 2009 Youth Smoking Prevalence, 2009 Tobacco Control Report from the Region of the Americas 2011

PROPORTION OF PATIENTS WITH COPD WHO ARE NON-SMOKERS Salvi and Barnes. Lancet 2009

 85% of all global particulate exposure occurs indoors  HAP levels are typically higher than developed world standards for ambient air quality  EPA Standard: 150 micrograms/cubed meter  Households with HAP:  During cooking 30,000  50x more carbon monoxide HOUSEHOLD AIR POLLUTION HAP in Nigeria door_air_pollution.shtml

DIABETES AND HIGH BLOOD SUGAR

Health Statistics and Informatics Leading causes of attributable global mortality and burden of disease, 2004 % 1.High blood pressure Tobacco use8.7 3.High blood glucose Physical inactivity Overweight and obesity High cholesterol Unsafe sex Alcohol use3.8 9.Childhood underweight Indoor smoke from solid fuels million total global deaths in 2004 % 1.Childhood underweight Unsafe sex4.6 3.Alcohol use4.5 4.Unsafe water, sanitation, hygiene High blood pressure3.7 6.Tobacco use3.7 7.Suboptimal breastfeeding High blood glucose Indoor smoke from solid fuels Overweight and obesity billion total global DALYs in 2004 Attributable MortalityAttributable DALYs

EPICENTERS OF DIABETES Deaths from diabetes

Hu. Diabetes Care 2011

The Epidemiologic Transition DescriptionLife Expectancy % deaths from CV Dominant CVDs Stage 1 Pestilence and Famine Malnutrition Infectious diseases 35 years<10Infectious (RHD) Nutritional Stage 2 Receding pandemics Improved nutrition and public health Chronic disease Hypertension 50 years10-35Infectious (RHD) Stroke-haemorrhagic Stage 3 Degenerative and man-made diseases High fat and caloric intake Tobacco use Chronic diseases > infectious, malnutrition >60 years35-65Ischemic heart disease (IHD) Stroke – haemorrhagic, ischaemic Stage 4 Delayed degenerative diseases Leading causes of mortality CV and cancer deaths Prevention and treatment delays onset Age-adjusted CV death reduced >70 years40-50IHD Stroke – ischaemic CHF From Gersh et al. European Heart Journal 2010

THE PERFECT STORM OF CVD IN LMICS Gersh et al. EHJ 2010 LMICs: low- and middle-income countries

Development Diet Tobacco Sedentary lifestyle Technology Urbanization Industry

Projected Deaths by Cause Beaglehole and Bonita. Lancet 2008

WHERE DO WE GO FROM HERE?

PERCENT OF CVD STUDIES FROM SSA BY COUNTRY/REGION,

CONTEMPORARY CAUSES OF HEART FAILURE IN SSA Bloomfield et al. Curr Cardiol Reviews 2013

“FLTR” FOR NCDS  Find  Link  Treat  Retain HOSPITA L Health Center Dispensary COMMUNITY Current scenario Proposed scenario Optimizing Linkage and Retention to Hypertension Care in Kenya: LARK Hypertension Study. Slide courtesy of R. Vedanthan, Mt. Sinai

OPTIMIZING LINKAGE AND RETENTION TO HYPERTENSION CARE: LARK HYPERTENSION

Oxford Health Alliance 2006 AN OPPORTUNITY FOR PRIMARY PREVENTION

THE GOOD NEWS: PREVENTION WORKS

Non-Communicable Diseases in LMICs: Myths, Facts and Opportunities Gerald S. Bloomfield, MD, MPH Duke Global Health Institute Division of Cardiology Duke University THANK YOU